참고문헌
- A. Martins, H. Vieira, H. Gaspar, and S. Santos, Marketed marine natural products in the pharmaceutical and cosmeceutical industries: tips for success, Mar Drugs, 12(2), 1066 (2014). https://doi.org/10.3390/md12021066
- P. L. Gupta, M. Rajput, T. Oza, U. Trivedi, and G. Sanghvi, Eminence of microbial products in cosmetic industry, Nat Prod Bioprospect, 9(4), 267 (2019). https://doi.org/10.1007/s13659-019-0215-0
- N. Khan, D. N. Syed, N. Ahmad, and H. Mukhtar, Fisetin: a dietary antioxidant for health promotion, Antioxid Redox Signal, 19(2), 151 (2013). https://doi.org/10.1089/ars.2012.4901
- W. Li, L. Qin, R. Feng, G. Hu, H. Sun, Y. He, and R. Zhang, Emerging senolytic agents derived from natural products, Mech Ageing Dev, 181, 1 (2019). https://doi.org/10.1016/j.mad.2019.05.001
- Y. Arai, S. Watanabe, M. Kimira, K. Shimoi, R. Mochizuki, and N. Kinae, Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration, J Nutr, 130(9), 2243 (2000). https://doi.org/10.1093/jn/130.9.2243
- K. Sundarraj, A. Raghunath, and E. Perumal, A review on the chemotherapeutic potential of fisetin: In vitro evidences, Biomed Pharmacother, 97, 928 (2018). https://doi.org/10.1016/j.biopha.2017.10.164
- Y. Zhu, E. J. Doornebal, T. Pirtskhalava, N. Giorgadze, M. Wentworth, H. Fuhrmann-Stroissnigg, L. J. Niedernhofer, P. D. Robbins, T. Tchkonia, and J. L. Kirkland, New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463, Aging (Albany NY), 9(3), 955 (2017). https://doi.org/10.18632/aging.101202
- K. Ishige, D. Schubert, and Y. Sagara, Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms, Free Radic Biol Med, 30(4), 433 (2001). https://doi.org/10.1016/S0891-5849(00)00498-6
- Z. S. Markovic, S. V. Mentus, and J. M. Dimitric Markovic, Electrochemical and density functional theory study on the reactivity of fisetin and its radicals: implications on in vitro antioxidant activity, J Phys Chem A, 113(51), 14170 (2009). https://doi.org/10.1021/jp907071v
- Y. S. Touil, J. Seguin, D. Scherman, and G. G. Chabot, Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinomabearing mice, Cancer Chemother Pharmacol, 68(2), 445 (2011). https://doi.org/10.1007/s00280-010-1505-8
- N. Ravichandran, G. Suresh, B. Ramesh, and G. V. Siva, Fisetin, a novel flavonol attenuates benzo(a) pyrene-induced lung carcinogenesis in Swiss albino mice, Food Chem Toxicol, 49(5), 1141 (2011). https://doi.org/10.1016/j.fct.2011.02.005
- N. Khan, M. Asim, F. Afaq, M. Abu Zaid, and H. Mukhtar, A novel dietary flavonoid fisetin inhibits androgen receptor signaling and tumor growth in athymic nude mice, Cancer Res, 68(20), 8555 (2008). https://doi.org/10.1158/0008-5472.CAN-08-0240
- P. Maher, T. Akaishi, and K. Abe, Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory, Proc Natl Acad Sci U S A, 103(44), 16568 (2006). https://doi.org/10.1073/pnas.0607822103
- Y. Sagara, J. Vanhnasy, and P. Maher, Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal-regulated kinase activation, J Neurochem, 90(5), 1144 (2004). https://doi.org/10.1111/j.1471-4159.2004.02563.x
- M. S. Shon, R. H. Kim, O. J. Kwon, S. S. Roh, and G. N. Kim, Beneficial role and function of fisetin in skin health via regulation of the CCN2/TGF-beta signaling pathway, Food Sci Biotechnol, 25(Suppl 1), 133 (2016). https://doi.org/10.1007/s10068-016-0110-y
- M. Kimira, Y. Arai, K. Shimoi, and S. Watanabe, Japanese intake of flavonoids and isoflavonoids from foods, J Epidemiol, 8(3), 168 (1998). https://doi.org/10.2188/jea.8.168
- H. C. Pal, R. D. Baxter, K. M. Hunt, J. Agarwal, C. A. Elmets, M. Athar, and F. Afaq, Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells, Oncotarget, 6(29), 28296 (2015). https://doi.org/10.18632/oncotarget.5064
- A. Sabarwal, R. Agarwal, and R. P. Singh, Fisetin inhibits cellular proliferation and induces mitochondriadependent apoptosis in human gastric cancer cells, Mol Carcinog, 56(2), 499 (2017). https://doi.org/10.1002/mc.22512
- W. Kim and J. W. Shay, Long-range telomere regulation of gene expression: Telomere looping and telomere position effect over long distances (TPE-OLD), Differentiation, 99, 1 (2018). https://doi.org/10.1016/j.diff.2017.11.005
- I. Flores, M. L. Cayuela, and M. A. Blasco, Effects of telomerase and telomere length on epidermal stem cell behavior, Science, 309(5738), 1253 (2005). https://doi.org/10.1126/science.1115025
- N. Liu, Y. Yin, H. Wang, Z. Zhou, X. Sheng, H. Fu, R. Guo, H. Wang, J. Yang, P. Gong, W. Ning, Z. Ju, Y. Liu, and L. Liu, Telomere dysfunction impairs epidermal stem cell specification and differentiation by disrupting BMP/pSmad/P63 signaling, PLoS Genet, 15(9), e1008368 (2019). https://doi.org/10.1371/journal.pgen.1008368
- A. L. Gartel and S. K. Radhakrishnan, Lost in transcription: p21 repression, mechanisms, and consequences, Cancer Res, 65(10), 3980 (2005). https://doi.org/10.1158/0008-5472.CAN-04-3995
- I. M. Chu, L. Hengst, and J. M. Slingerland, The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy, Nat Rev Cancer, 8(4), 253 (2008). https://doi.org/10.1038/nrc2347
- T. Tsutsui, B. Hesabi, D. S. Moons, P. P. Pandolfi, K. S. Hansel, A. Koff, and H. Kiyokawa, Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity, Mol Cell Biol, 19(10), 7011 (1999). https://doi.org/10.1128/mcb.19.10.7011
- N. Khan, F. Afaq, F. H. Khusro, V. Mustafa Adhami, Y. Suh, and H. Mukhtar, Dual inhibition of phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin, Int J Cancer, 130(7), 1695 (2012). https://doi.org/10.1002/ijc.26178
- X. Lu, J. Jung, H. J. Cho, D. Y. Lim, H. S. Lee, H. S. Chun, D. Y. Kwon, and J. H. Park, Fisetin inhibits the activities of cyclin-dependent kinases leading to cell cycle arrest in HT-29 human colon cancer cells, J Nutr, 135(12), 2884 (2005). https://doi.org/10.1093/jn/135.12.2884
- R. A. Hiipakka, H. Z. Zhang, W. Dai, Q. Dai, and S. Liao, Structure-activity relationships for inhibition of human 5alpha-reductases by polyphenols, Biochem Pharmacol, 63(6), 1165 (2002). https://doi.org/10.1016/S0006-2952(02)00848-1
- A. Q. Haddad, V. Venkateswaran, L. Viswanathan, S. J. Teahan, N. E. Fleshner and L. H. Klotz, Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines, Prostate Cancer Prostatic Dis, 9(1), 68 (2006). https://doi.org/10.1038/sj.pcan.4500845
- I. Murtaza, V. M. Adhami, B. B. Hafeez, M. Saleem, and H. Mukhtar, Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inh,ibition of NF-kappaB, Int J Cancer, 125(10), 2465 (2009). https://doi.org/10.1002/ijc.24628
- D. N. Syed, F. Afaq, N. Maddodi, J. J. Johnson, S. Sarfaraz, A. Ahmad, V. Setaluri, and H. Mukhtar, Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/beta-catenin signaling and decreased Mitf levels, J Invest Dermatol, 131(6), 1291 (2011). https://doi.org/10.1038/jid.2011.6
- A. L. Slusher, J. J. Kim, and A. T. Ludlow, The Role of Alternative RNA Splicing in the Regulation of hTERT, Telomerase, and Telomeres: Implications for Cancer Therapeutics, Cancers (Basel), 12(6), (2020).
- J. W. Shay and W. E. Wright, Telomeres and telomerase in normal and cancer stem cells, FEBS Lett, 584(17), 3819 (2010). https://doi.org/10.1016/j.febslet.2010.05.026
- C. B. Harley, Telomerase is not an oncogene, Oncogene, 21(4), 494 (2002). https://doi.org/10.1038/sj.onc.1205076
- J. W. Shay and W. E. Wright, Senescence and immortalization: role of telomeres and telomerase, Carcinogenesis, 26(5), 867 (2005). https://doi.org/10.1093/carcin/bgh296
- P. M. Elias, Skin barrier function, Curr Allergy Asthma Rep, 8(4), 299 (2008). https://doi.org/10.1007/s11882-008-0048-0
- I. R. Scott and C. R. Harding, Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment, Dev Biol, 115(1), 84 (1986). https://doi.org/10.1016/0012-1606(86)90230-7
- C. N. Palmer, A. D. Irvine, A. Terron-Kwiatkowski, Y. Zhao, H. Liao, S. P. Lee, D. R. Goudie, A. Sandilands, L. E. Campbell, F. J. Smith, G. M. O'Regan, R. M. Watson, J. E. Cecil, S. J. Bale, J. G. Compton, J. J. DiGiovanna, P. Fleckman, S. Lewis-Jones, G. Arseculeratne, A. Sergeant, C. S. Munro, B. El Houate, K. McElreavey, L. B. Halkjaer, H. Bisgaard, S. Mukhopadhyay, and W. H. McLean, Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis, Nat Genet, 38(4), 441 (2006). https://doi.org/10.1038/ng1767
- B. E. Kim, D. Y. Leung, M. Boguniewicz, and M. D. Howell, Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6, Clin Immunol, 126(3), 332 (2008). https://doi.org/10.1016/j.clim.2007.11.006
- Z. Nemes, L. N. Marekov, L. Fesus, and P. M. Steinert, A novel function for transglutaminase 1: attachment of long-chain omega-hydroxyceramides to involucrin by ester bond formation, Proc Natl Acad Sci U S A, 96(15), 8402 (1999). https://doi.org/10.1073/pnas.96.15.8402
- L. Polivka, S. Hadj-Rabia, E. Bal, S. Leclerc-Mercier, M. Madrange, Y. Hamel, D. Bonnet, S. Mallet, H. Lepidi, C. Ovaert, P. Barbet, C. Dupont, B. Neven, A. Munnich, L. M. Godsel, F. Campeotto, R. Weil, E. Laplantine, S. Marchetto, J. P. Borg, W. I. Weis, J. L. Casanova, A. Puel, K. J. Green, C. Bodemer, and A. Smahi, Epithelial barrier dysfunction in desmoglein-1 deficiency, J Allergy Clin Immunol, 142(2), 702 (2018). https://doi.org/10.1016/j.jaci.2018.04.007
- G. Mocsai, K. Gaspar, G. Nagy, B. Irinyi, A. Kapitany, T. Biro, E. Gyimesi, B. Toth, L. Marodi, and A. Szegedi, Severe skin inflammation and filaggrin mutation similarly alter the skin barrier in patients with atopic dermatitis, Br J Dermatol, 170(3), 617 (2014). https://doi.org/10.1111/bjd.12743
- H. Green and P. Djian, Consecutive actions of different gene-altering mechanisms in the evolution of involucrin, Mol Biol Evol, 9(6), 977 (1992).
- D. Garrod and M. Chidgey, Desmosome structure, composition and function, Biochim Biophys Acta, 1778(3), 572 (2008). https://doi.org/10.1016/j.bbamem.2007.07.014
- R. L. Eckert, M. T. Sturniolo, A. M. Broome, M. Ruse and E. A. Rorke, Transglutaminase function in epidermis, J Invest Dermatol, 124(3), 481 (2005). https://doi.org/10.1111/j.0022-202X.2005.23627.x
- D. Davis, M. Kannan and B. Wattenberg, Orm/ORMDL proteins: Gate guardians and master regulators, Adv Biol Regul, 70, 3 (2018). https://doi.org/10.1016/j.jbior.2018.08.002
- L. Coderch, O. Lopez, A. de la Maza and J. L. Parra, Ceramides and skin function, Am J Clin Dermatol, 4(2), 107 (2003). https://doi.org/10.2165/00128071-200304020-00004
- M. Rabionet, K. Gorgas and R. Sandhoff, Ceramide synthesis in the epidermis, Biochim Biophys Acta, 1841(3), 422 (2014). https://doi.org/10.1016/j.bbalip.2013.08.011
- M. Levy and A. H. Futerman, Mammalian ceramide synthases, IUBMB Life, 62(5), 347 (2010).
- H. J. Cha, C. He, H. Zhao, Y. Dong, I. S. An and S. An, Intercellular and intracellular functions of ceramides and their metabolites in skin (Review), Int J Mol Med, 38(1), 16 (2016). https://doi.org/10.3892/ijmm.2016.2600